Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Oncorus Reports Fourth Quarter and Full Year 2022 Financial
Reprioritized product portfolio to focus on IV-administered,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Oncorus
Oncorus to Participate in Upcoming Investor Conferences
ANDOVER, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief…
Oncorus Presents Preclinical Data Supporting ONCR-719, an
ONCR-719 is uniquely engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry, which is highly expressed in glioblastoma multiforme (GBM); data show that the canonical entry receptor for HSV-1, NECTIN-1, is…